Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
06/08/2024 09:53
Aug 6 (Reuters) - Amniotics AB (publ) AMNI.ST :
* RECEIVES CONDITIONAL APPROVAL TO DELIST FROM NASDAQ FIRST
NORTH
GROWTH MARKET
* SUBJECT TO PERMISSION, LAST DAY OF TRADING ON NASDAQ FIRST
NORTH
GROWTH MARKET SHALL BE SEPT 27 2024
Source text for Eikon: ID:nMFN24Qn0Y
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan